Show results for
Refine by
Locations
- USA
- Alabama
- Alaska
- Arizona
- Arkansas
- California
- Colorado
- Connecticut
- Delaware
- District Of Columbia
- Florida
- Georgia (Us)
- Hawaii
- Idaho
- Illinois
- Indiana
- Iowa
- Kansas
- Kentucky
- Louisiana
- Maine
- Maryland
- Massachusetts
- Michigan
- Minnesota
- Mississippi
- Missouri
- Montana
- Nebraska
- Nevada
- New Hampshire
- New Jersey
- New Mexico
- New York
- North Carolina
- North Dakota
- Ohio
- Oklahoma
- Oregon
- Pennsylvania
- Rhode Island
- South Carolina
- South Dakota
- Tennessee
- Texas
- Utah
- Vermont
- Virginia
- Washington
- West Virginia
- Wisconsin
- Wyoming
Venous System Suppliers In Usa
9 companies found
based inSalt Lake City, UTAH (USA)
At Health Line, our mission is to be one of the world’s leading manufacturers of vascular access, infusion therapy, and infection control products. We are committed to upholding strong quality management and regulatory systems to meet the demands of ...
The Health Line CT Midline Catheter is intended for short-term (less than 30 days) peripheral access to the venous system for the purpose of intravenous therapy, medicines, and blood products. A single midline IV ...
based inKyoto, JAPAN
As a company that contributes to improving global medical skills. Currently we are focusing our business resources on the medical training simulator and practice model field. We will continue to expand our field of vision from Kyoto to encompass the ...
A new abdominal phantom to conduct studies and training of fusion imaging for wide range of clinical applications. (CT & ...
based inPlymouth, MINNESOTA (USA)
We are focused on the development and commercialization of biological medical devices manufactured using a proprietary perfusion decellularization technology that supports cellular integration. Reprise Biomedical, Inc. was created in connection with ...
Our proprietary perfusion decellularization process involves cannulating the main vasculature of the organ and perfusing a mild detergent solution through the native blood vessels to result in a preserved native scaffold containing the appropriate ...
based inPearland, TEXAS (USA)
Our mission is the development of absorbable medical devices with the premise that implants should be safe and effective during their useful lifetime, and then simply vanish without intervention, alleviating costly removal procedures and downstream ...
Although conventional metal IVC filters can reduce the incidence of PE to 1-2%, many are fraught with mounting complications as they remain in the body for prolonged duration. Most IVC filters are placed with the intention to be retrieved within ...
based inPrairie Village, KANSAS (USA)
At Artio, we are committed to developing and commercializing novel, best-in-class medical devices that have the potential to provide better patient outcomes. Delivering innovative medical devices with the potential to provide impactful solutions to ...
Innovative vein dilation system for hemodialysis patients. The Amplifi Vein Dilation System is designed to stimulate arm vein enlargement in hemodialysis patients using rapid, non-pulsatile blood flow. The Amplifi System aims to increase eligibility ...
based inBillerica, MASSACHUSETTS (USA)
Access Vascular is offering a suite of vascular access devices that use our novel, patented biomaterial featuring MIMIX™ technology which is designed to prevent the most common and costly complications in vascular access. Keep treatment moving ...
A peripherally inserted central venous catheter (PICC) is a central line used to gain vascular access with its tip extending to the superior vena ...
based inSanta Clara, CALIFORNIA (USA)
Cardiva Medical, Inc. is a privately held medical device company focused on transforming vascular closure for the benefit of patients, hospitals and physicians in the over 5.5 million catheter-based coronary, peripheral and electrophysiology ...
VASCADE MVP eliminates the need for manual compression and reduces time to ambulation by 64%. Get patients up and moving hours earlier, with significantly less discomfort. The only FDA-approved closure device for use following cardiac ...
based inNew York, NEW YORK (USA)
Protara is committed to identifying and advancing transformative therapies for people with cancer and rare diseases. The Protara team prioritizes creativity, diverse perspectives and tenacity to expedite our goal of bringing life-changing therapies ...
TARA-002 is an investigational cell therapy in development for the treatment of non-muscle invasive bladder cancer (NMIBC) and lymphatic malformations (LMs). TARA-002 was developed from the same master cell bank of genetically distinct group A ...
based inSilver Spring, MARYLAND (USA)
We are the first publicly-traded biotech or pharmaceutical company to take the form of a public benefit corporation (PBC). Our public benefit purpose is to provide a brighter future for patients through (a) the development of novel pharmaceutical ...
The most widely recognized method of removing cells in use today is “immersion decellularization” in which a tissue or organ is soaked in strong detergent which diffuses from the outer surface inward, and then back out once the cells are ...